CSRXP APPLAUDS EXPANDED FTC CRACK DOWN ON BIG PHARMA’S SHAM PATENTS IN THE ORANGE BOOK
Commission Builds on Previous Action by Targeting More Than 300 Patents, Including on Blockbuster GLP-1 Weight Loss Drugs Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to an announcement from the Federal Trade Commission (FTC) that the Commission is challenging more than 300 patents listed in the U.S. Food and Drug Administration’s